3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rectal Neoplasms
29
Esophageal Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
15
Carcinoma, Non-Small-Cell Lung
14
Nasopharyngeal Carcinoma
12
Uterine Cervical Neoplasms
11
Head and Neck Neoplasms
11
Pancreatic Neoplasms
8
Oropharyngeal Neoplasms
8
Lung Neoplasms
6
Glioblastoma
6
Carcinoma, Squamous Cell
5
Urinary Bladder Neoplasms
4
Stomach Neoplasms
4
Mouth Neoplasms
4
Hypopharyngeal Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Colorectal Neoplasms
4
Adenocarcinoma
4
Radiation Injuries
3
Pathologic Complete Response
3
Carcinoma
3
Breast Neoplasms
3
Thymoma
2
Resectable Esophageal Cancer
2
Neoplasms
2
Nasopharyngeal Neoplasms
2
NSCLC
2
Lymphoma
2
Lymphatic Metastasis
2
Interventions
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Overall Survival Comparison Between the 2 Arms
×
Chemoradiotherapy
×
Clear all
NCT02848716
2021-11-17
LiLACs
Institut Claudius Regaud
Phase 3
Withdrawn